Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage

PHASE3CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

November 10, 2016

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions
Trypanosomiasis, AfricanSleeping SicknessTrypanosomiasis; Gambian
Interventions
DRUG

Fexinidazole

Tablets of 600 mg; Participants with a weight between 20 and 34 kg received 1200 mg (2 tablets) for 4 days, then 600 mg (1 tablet) for 6 days (with food); Participants with a weight of 35 kg and above received 1800 mg (3 tablets) for 4 days, then 1200 mg (2 tablets) for 6 days (with food)

Trial Locations (8)

Unknown

Dipumba Hospital, Mbuji-Mayi

Bagata Hospital, Bagata

Bandundu Hospital, Bandundu Province

Masi Manimba Hospital, Masi-Manimba

Nkara Secondary Hospital, Nkara

Mushie Hospital, Mushie

Roi Baudouin Hospital, Kinshasa

Dubreka Hospital, Dubréka

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Drugs for Neglected Diseases

OTHER